Supplementary_table1.docx (16.33 kB)
Supplementary data: Idarucizumab (Praxbind®) for dabigatran reversal in patients undergoing heart transplantation: a cohort of 10 patients.docx
dataset
posted on 2021-02-15, 20:20 authored by Eran Kalmanovich, Pascal Battistella, Philippe Rouviere, Bernard Albat, Jean-Marc Frapier, Roland Demaria, Audrey Agullo, Marc Mourad, Pascal Colson, Florence Leclercq, Philippe Gaudard, François Roubille, Fabien HuetSupplementary Table 1. Idarucizumab (Praxbind®) for dabigatran reversal in patients undergoing heart transplantation: a cohort of 10 patients
Baseline characteristics of the patients.
